Description
Overview CJC-1295 No DAC & Ipamorelin Peptide Blend
CJC-1295 No DAC 5MG & Ipamorelin 5MG blend was researched and produced for research purpose in studies relating to endocrinology and growth hormone related subjects. This mixture offers two well known peptides in one lyophilized product for use in laboratory studies.
Our CJC-1295 (No DAC) and Ipamorelin combination product in a 3ml glass vial is each dosed with 5mg of their respective compounds to give a 10mg dose. These research chemicals are >99% pure, and have been tested by a third party.
Key Features
- Dual Peptide Combination: Includes CJC-1295 (No DAC) and Ipamorelin.
- High Purity (≥99%): Ensures consistency and reproducibility.
- Third-Party Verified: Independent testing confirms quality.
- Lyophilized Format: Enhances stability and storage longevity.
Product Specifications
- Contents: 5mg CJC-1295 (No DAC) / 5mg Ipamorelin
- Total Content: 10mg per vial
- Vial Size: 3mL glass ampule
- Purity: ≥99%
- Appearance: White lyophilized powder
- Reconstitution: Required using sterile solution
Scientific Background
Ipamorelin and CJC-1295 (no DAC) What is it? CJC-1295 (no DAC) is synthetic analog that mimics a hormone called GHRH (growth hormone releasing hormone), and Ipamorelin works by selectively targetingghrelin receptors, which plays a key part in stimulating your growth hormone release.
Both GHRH analogs and ghrelin mimetics were previously employed in our laboratory studies to evaluate pulsatile secretion of a particular hormone and its receptor interaction, and used together they helped to explore mechanisms related to them more broadly than did use of any single compounds in the research that were found within a database in PubMed.
Mechanism of Action
In research applications CJC-1295 (No DAC) acts as a GH releasing factor analog that will increase the secretion of GH by mimicking the function of endogenous GHRH, and Ipamorelin acts to selectively bind the ghrelin receptor to initiate another pathway of increased growth hormone production. The combination is tested for a synergizing effect on hormone release.
Research Applications
- Growth hormone signaling studies
- Endocrine system research
- Peptide interaction analysis
- Receptor binding and activation studies
Comparison to Individual Peptides
By using a combination of CJC-1295 and Ipamorelin in an appropriate research setting, there can be a greater range with which one can research hormonal effects in the human body than by simply utilizing one compound on its own, and thus one can see whether it helps or hurts any complementary or synergistic effects that they may cause on the body.
Reconstitution and Handling
Product to be reconstituted prior to use. A sterile diluent such as bacteriostatic water or a recommended reconstitution solution is advisable. Appropriate sterile handling and technique should be utilized to maintain compound integrity.
Storage Guidelines
Store at or below 6 C in a tightly sealed container and away from light, heat and moisture. It is extremely important that the peptide is stored properly to protect the structure and functionality.
Quality Assurance
Each peptide mixture is subjected to thorough third-party verification to guarantee their authenticity, integrity, and consistency. This commitment to quality and high standards provides researchers with confidence in their products.
Important Considerations
- For laboratory research use only
- Not approved for human or veterinary use
- Use only by qualified professionals
- Follow all laboratory safety protocols
Frequently Asked Questions
What is this blend used for?
It is used in research to study growth hormone signaling and peptide interactions.
Why combine CJC-1295 and Ipamorelin?
The combination allows researchers to investigate complementary mechanisms of hormone release.
Is reconstitution required?
Yes, the lyophilized powder must be reconstituted using a sterile solution before use.
